|
Negative regulation of CD8-positive, alpha-beta T cell activation |
> 100 |
4.26E-05 |
1.32E-02 |
LILRB1, SOCS1
|
Interferon-gamma production |
> 100 |
8.35E-05 |
2.31E-02 |
ISG15, LILRB1
|
T cell chemotaxis |
> 100 |
1.81E-04 |
4.21E-02 |
CXCL10, CXCL11
|
Positive regulation of release of sequestered calcium ion into cytosol |
56.58 |
2.44E-05 |
8.74E-03 |
CXCL10, CXCL11, CXCL9
|
Type I interferon signaling pathway |
46.6 |
1.93E-06 |
1.38E-03 |
ISG15, IFI35, RSAD2, ISG20
|
Negative regulation of viral genome replication |
44.01 |
4.98E-05 |
1.48E-02 |
ISG15, RSAD2, ISG20
|
Neutrophil chemotaxis |
41.15 |
3.09E-06 |
1.81E-03 |
CXCL10, CXCL11, CCL8, CXCL9
|
Chemokine-mediated signaling pathway |
40.11 |
3.41E-06 |
1.85E-03 |
CXCL10, CXCL11, CCL8, CXCL9
|
Killing of cells of other organisms |
37.72 |
4.31E-06 |
2.19E-03 |
CXCL10, CXCL11, CCL8, CXCL9
|
Antimicrobial humoral immune response mediated by antimicrobial peptide |
30.76 |
9.38E-06 |
3.70E-03 |
CXCL10, CXCL11, CCL8, CXCL9
|